Hepion Pharmaceuticals Inc (HEPA)

$0.14 -0.18 (-57.55%)
Market Cap 4.28M
Revenue (ttm) 0.00
Net Income (ttm) -13.19M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,907,500
Avg Vol 5,820,207
Day's Range N/A - N/A
Shares Out 10.93M
Stochastic %K 55%
Beta 1.90
Analysts Strong Buy
Price Target $30.00

Company Profile

Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), metabolic liver diseases, and chronic liver diseases in the United States. It developed Rencofilstat, a therapeutic drug candidate that binds and inhibits the function of a specific class of isomerase enzymes called cyclophilins that regulates protein folding, as well as preclinical experiments of Rencofilstat reflects decreased liver fibrosis; liver inflammation...

Industry: Biotechnology
Sector: Healthcare
Phone: 732 902 4000
Address:
55 Madison Avenue, Suite 400 PMB No. 4362, Morristown, United States
justice_for_all
justice_for_all Apr. 28 at 5:03 PM
$HEPA HEPA is a zombie biotech — extremely distressed, heavily diluted, barely surviving, but not dead. It can continue limping along through micro‑financings, reverse splits, and filings, but the probability of long‑term recovery is extremely low without a major catalyst. IN OTHER WORDS = SCAM!
0 · Reply
prismmarketview
prismmarketview Apr. 27 at 4:15 PM
PRISM Mid-Day Movers: Pharmaceuticals and Weight Loss are Today’s Leaders. Shares of Hepion Pharmaceuticals, Inc. (OTC: $HEPA) are moving higher, with the stock up about 23% today to $0.0503 as very light absolute dollar flows translate into large percentage gains in this sub‑$1 million market‑cap name Shares of WW International, Inc. (Nasdaq: $WW) are ripping higher, trading at $11.32, up 22.11% on the day after opening at $9.60 and hitting an intraday high of $11.72 on volume of 781,313 shares versus an average of 313,427. Other Notable Movers: LifeVantage ( $LFVN) up 15% Momentus Inc. ( $MNTS) up 13% POET Technologies Inc., ( $POET) down -45% prismmarketview.com/prism-m...
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Apr. 27 at 12:30 PM
$HEPA CEO purchased 1,250,000 shares at $0.04 for a total of $50,000. Stetz Gary S. now owns 1,250,000 shares. https://ceo-buys.com
0 · Reply
aiolus
aiolus Apr. 23 at 1:00 PM
$HEPA Everyone should read HEPA’s latest filings carefully. In the 4/22/2026 8-K, Hepion says it sold 17,500,000 shares at $0.04 for total gross proceeds of $700,000 in a private placement. In the Form D for the same offering, the company reports: $700,000 total offering amount $700,000 sold 11 investors $0 sales commissions $0 finders’ fees. The part that stands out to me is Item 16 of the Form D. It says that $700,000 of the gross proceeds “has been or is proposed to be used for payments to” the persons named in Item 3, which lists company executives/directors. I am not claiming illegality, but if I am reading this correctly, this looks like very heavy dilution and the filing appears to say the proceeds were used or intended to be used for payments to insiders. Read the 8-K and Form D yourself and decide.
1 · Reply
Moneybucks
Moneybucks Apr. 22 at 10:41 PM
$HEPA Massive dilution you fools holding onto shares😂
0 · Reply
Moneybucks
Moneybucks Apr. 22 at 10:24 PM
$HEPA https://www.sec.gov/ix?doc=/Archives/edgar/data/0001583771/000149315226018575/form8-k.htm
0 · Reply
Opusone2010
Opusone2010 Apr. 16 at 10:51 PM
$HEPA 😂 this MC is lower than my investment property.. What a garbage dump!
0 · Reply
BADBOYROY
BADBOYROY Apr. 14 at 8:40 PM
$HEPA as Pharm calls her, ole Dr. Labia get $250,000 cash for literally doing nothing. What a way to live. https://s3.amazonaws.com/sec.irpass.cc/2652/0001493152-26-016557.htm
1 · Reply
prismmarketview
prismmarketview Mar. 30 at 4:35 PM
PRISM Mid-Day Movers: Healthcare and Aerospace & Defense are Today's Leaders. Bullfrog AI Holdings (NASDAQ: $BFRG) is ripping higher, up about 126% on a massive volume spike as this ultra‑low‑float, AI‑driven drug discovery micro‑cap becomes a momentum target in high‑risk territory. Astrotech (NASDAQ: $ASTC) is also soaring, recently up roughly 115–120% as heavy volume re‑rates the ultra‑thin micro‑cap off its lows despite a sub‑$10M market cap, negative EPS and a history of sharp volatility. Other Notable Movers: Iterum Therapeutics plc ($ITRM) up 75% Hepion Pharmaceuticals ( $HEPA) up 19% IceCure Medical ( $ICCM) down -22%
0 · Reply
beacher
beacher Mar. 26 at 11:57 AM
$HEPA Lucky I had a very small position here... I believe I will never see any money here😅
0 · Reply
Latest News on HEPA
No data available.
justice_for_all
justice_for_all Apr. 28 at 5:03 PM
$HEPA HEPA is a zombie biotech — extremely distressed, heavily diluted, barely surviving, but not dead. It can continue limping along through micro‑financings, reverse splits, and filings, but the probability of long‑term recovery is extremely low without a major catalyst. IN OTHER WORDS = SCAM!
0 · Reply
prismmarketview
prismmarketview Apr. 27 at 4:15 PM
PRISM Mid-Day Movers: Pharmaceuticals and Weight Loss are Today’s Leaders. Shares of Hepion Pharmaceuticals, Inc. (OTC: $HEPA) are moving higher, with the stock up about 23% today to $0.0503 as very light absolute dollar flows translate into large percentage gains in this sub‑$1 million market‑cap name Shares of WW International, Inc. (Nasdaq: $WW) are ripping higher, trading at $11.32, up 22.11% on the day after opening at $9.60 and hitting an intraday high of $11.72 on volume of 781,313 shares versus an average of 313,427. Other Notable Movers: LifeVantage ( $LFVN) up 15% Momentus Inc. ( $MNTS) up 13% POET Technologies Inc., ( $POET) down -45% prismmarketview.com/prism-m...
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Apr. 27 at 12:30 PM
$HEPA CEO purchased 1,250,000 shares at $0.04 for a total of $50,000. Stetz Gary S. now owns 1,250,000 shares. https://ceo-buys.com
0 · Reply
aiolus
aiolus Apr. 23 at 1:00 PM
$HEPA Everyone should read HEPA’s latest filings carefully. In the 4/22/2026 8-K, Hepion says it sold 17,500,000 shares at $0.04 for total gross proceeds of $700,000 in a private placement. In the Form D for the same offering, the company reports: $700,000 total offering amount $700,000 sold 11 investors $0 sales commissions $0 finders’ fees. The part that stands out to me is Item 16 of the Form D. It says that $700,000 of the gross proceeds “has been or is proposed to be used for payments to” the persons named in Item 3, which lists company executives/directors. I am not claiming illegality, but if I am reading this correctly, this looks like very heavy dilution and the filing appears to say the proceeds were used or intended to be used for payments to insiders. Read the 8-K and Form D yourself and decide.
1 · Reply
Moneybucks
Moneybucks Apr. 22 at 10:41 PM
$HEPA Massive dilution you fools holding onto shares😂
0 · Reply
Moneybucks
Moneybucks Apr. 22 at 10:24 PM
$HEPA https://www.sec.gov/ix?doc=/Archives/edgar/data/0001583771/000149315226018575/form8-k.htm
0 · Reply
Opusone2010
Opusone2010 Apr. 16 at 10:51 PM
$HEPA 😂 this MC is lower than my investment property.. What a garbage dump!
0 · Reply
BADBOYROY
BADBOYROY Apr. 14 at 8:40 PM
$HEPA as Pharm calls her, ole Dr. Labia get $250,000 cash for literally doing nothing. What a way to live. https://s3.amazonaws.com/sec.irpass.cc/2652/0001493152-26-016557.htm
1 · Reply
prismmarketview
prismmarketview Mar. 30 at 4:35 PM
PRISM Mid-Day Movers: Healthcare and Aerospace & Defense are Today's Leaders. Bullfrog AI Holdings (NASDAQ: $BFRG) is ripping higher, up about 126% on a massive volume spike as this ultra‑low‑float, AI‑driven drug discovery micro‑cap becomes a momentum target in high‑risk territory. Astrotech (NASDAQ: $ASTC) is also soaring, recently up roughly 115–120% as heavy volume re‑rates the ultra‑thin micro‑cap off its lows despite a sub‑$10M market cap, negative EPS and a history of sharp volatility. Other Notable Movers: Iterum Therapeutics plc ($ITRM) up 75% Hepion Pharmaceuticals ( $HEPA) up 19% IceCure Medical ( $ICCM) down -22%
0 · Reply
beacher
beacher Mar. 26 at 11:57 AM
$HEPA Lucky I had a very small position here... I believe I will never see any money here😅
0 · Reply
Moneybucks
Moneybucks Mar. 25 at 9:56 PM
$HEPA New executive office 34 Shrewbury ave suite 1D. 🤔 Their is a hot dog stand across the street😂 look it up im not joking😂
0 · Reply
Moneybucks
Moneybucks Mar. 25 at 9:42 PM
$HEPA Last two items filed with patent office Fibrosis what its all
0 · Reply
Moneybucks
Moneybucks Mar. 25 at 9:37 PM
$HEPA https://ppubs.uspto.gov/api/patents/html/12409206?source=USPAT&requestToken=eyJzdWIiOiI0NmJjZDNkNy0xNDc1LTQ0NzctYTU0ZS0yOTllYTNiODBlMTgiLCJ2ZXIiOiI3ZWI1NmU4Mi04NTQyLTQzNmItOTRmNi0yNjMyYmRhZDgzODYiLCJleHAiOjB9
0 · Reply
Moneybucks
Moneybucks Mar. 25 at 9:36 PM
$HEPA https://ppubs.uspto.gov/api/patents/html/20250360181?source=US-PGPUB&requestToken=eyJzdWIiOiI0NmJjZDNkNy0xNDc1LTQ0NzctYTU0ZS0yOTllYTNiODBlMTgiLCJ2ZXIiOiI3ZWI1NmU4Mi04NTQyLTQzNmItOTRmNi0yNjMyYmRhZDgzODYiLCJleHAiOjB9
0 · Reply
Moneybucks
Moneybucks Mar. 25 at 1:09 PM
$HEPA https://hepionpharma.com/news/hepion-pharmaceuticals-discovers-novel-rencofilstat-action-in-liver-cancer/
0 · Reply
Moneybucks
Moneybucks Mar. 25 at 1:06 PM
$HEPA They post this on HCC about antifibrotics and need one safe and effective rencofilstat was it Rencofilstat belong back in hepion shareholders hands
1 · Reply
Moneybucks
Moneybucks Mar. 25 at 1:04 PM
$HEPA
0 · Reply
Moneybucks
Moneybucks Mar. 25 at 1:04 PM
$HEPA https://hepionpharma.com/hcc/
0 · Reply
theflynews
theflynews Mar. 23 at 3:48 PM
Biotech Alert: Searches spiking for these stocks today - $HEPA - https://thefly.com/HEPA
0 · Reply
BADBOYROY
BADBOYROY Mar. 21 at 3:43 AM
$HEPA https://www.bioworld.com/articles/727272-farsight-medical-technology-divulges-new-inhibitors-of-cyclophilin-a-and-d?v=preview
0 · Reply
BADBOYROY
BADBOYROY Mar. 21 at 3:30 AM
$HEPA China made sure renco never saw the light of day. Now they have their own version. https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(26)00071-6
0 · Reply
Moneybucks
Moneybucks Mar. 20 at 3:28 AM
$HEPA Tick Tock Tick Tock Taco has rung the bell😂
0 · Reply